Clinical Trials Sponsored by Jeil Pharmacy Co.

Total 640 results

Jun-Won Chung

Completed

Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial

Helicobacter Infected Patients

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Not yet recruiting

Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Recruiting

A Study of Lubiprostone to Treat Constipation

Constipation

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

Healthy Adult

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004

Healthy Adult

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects

Anti-Ulcer Agents

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

Diabetes | Hyperlipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin

Diabetes | Hyperlipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Hypertension With Dyslipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects.

Smoking, Cigarette

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

ANEURYSM CORONARY ARTERY
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Recruiting

Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects

Diabetes Mellitus

France
Jeil Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type 2 Diabetes Mellitus

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

Overactive Bladder(OAB)

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

Hypertension With Dyslipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

Diabetes | Hyperlipidemias

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia

Type 2 Diabetes | Dyslipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers

Diabetes | Hyperlipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

Essential Hypertension

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers (JPI-289)

Stroke

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS
Jeil Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type 2 Diabetes Mellitus

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

Healthy Adult

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder

Overactive Bladder

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Unknown

Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma Non-resectable

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Dyslipidemia With Hypertension

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma Non-resectable

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

Hypertension With Hyperlipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS(Lower Urinary Tract Symptoms)
Jeil Pharmaceutical Co., Ltd.

Completed

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

Hypertension | Hyperlipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

Stroke

Korea, Republic of
Ulsan University Hospital
Jeil Pharmaceutical Co., Ltd.

Unknown

Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma

Carcinoma, Non-Small-Cell Lung

Korea, Republic of
Onconic Therapeutics Inc.
Jeil Pharmaceutical Co., Ltd.

Completed

A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors

Advanced Solid Tumors

Korea, Republic of
Daejeon St. Mary's hospital
Jeil Pharmaceutical Co., Ltd.

Not yet recruiting

The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) (PPI)

Coronary Artery Disease
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Completed

Gemcitabine and S-1 for Advanced Biliary Tract Cancer

Biliary Tract Neoplasm

Korea, Republic of
National Cancer Center, Korea
Jeil Pharmaceutical Co., Ltd.

Unknown

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Advanced Non-Small Cell Lung Cancer

Korea, Republic of
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Unknown

Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer

Biliary Tract Neoplasm

Korea, Republic of
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Unknown

Docetaxel and S-1 for Advanced Esophageal Cancer

Esophageal Neoplasms

Korea, Republic of
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Completed

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Pancreas Neoplasms

Korea, Republic of
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Completed

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

Stomach Neoplasm

Korea, Republic of
The Catholic University of Korea
Jeil Pharmaceutical Co., Ltd.

Terminated

The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) (PIONEER)

Coronary Artery Disease | Atherosclerosis

Korea, Republic of
Shanxi Zhendong Pharmacy Co., Ltd

Recruiting

Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer

Radiation-induced Oral Mucositis

China
Hallym University Medical Center
Pfizer; HK inno.N Corporation; Handok Inc.; Jeil Pharmaceutical Co., Ltd.

Completed

S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer

Gastrointestinal Neoplasms

Korea, Republic of
Seoul National University Hospital
Kyowa Hakko Kirin Pharma, Inc.; Jeil-Kirin Pharmaceutical Inc.

Completed

Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493

Healthy

Korea, Republic of
Guangzhou JOYO Pharma Co., Ltd
Chengdu JOYO pharma Co., Ltd.

Not yet recruiting

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis
Chengdu JOYO pharma Co., Ltd.
Guangzhou JOYO Pharma Co., Ltd

Not yet recruiting

A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Shanton Pharma Co., Ltd.

Recruiting

Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Gout

United States, Puerto Rico

Clinical Trials Sponsored by Jeil Pharmacy Co.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations